| Year |
Citation |
Score |
| 2020 |
DeZern AE, Zahurak ML, Symons HJ, Cooke KR, Rosner GL, Gladstone DE, Huff CA, Swinnen LJ, Imus P, Borrello I, Wagner-Johnston N, Ambinder RF, Luznik L, Bolaños-Meade J, Fuchs EJ, et al. Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide. Blood Advances. 4: 1770-1779. PMID 32343796 DOI: 10.1182/Bloodadvances.2020001729 |
0.32 |
|
| 2018 |
Henderson NC, Louis TA, Rosner GL, Varadhan R. Individualized treatment effects with censored data via fully nonparametric Bayesian accelerated failure time models. Biostatistics (Oxford, England). PMID 30052809 DOI: 10.1093/Biostatistics/Kxy028 |
0.311 |
|
| 2014 |
Paller CJ, Rudek MA, Antonarakis ES, Eisenberger MA, Hammers HJ, Zhou XC, Dowling D, King S, Hudock S, Denmeade SR, Wagner WD, Rosner GL, Hudson T, Carducci MA. A phase I trial of muscadine grape skin in men with biochemically recurrent prostate cancer. Journal of Clinical Oncology. 32: 263-263. DOI: 10.1200/Jco.2014.32.4_Suppl.263 |
0.365 |
|
| 2010 |
Hennessey VG, Rosner GL, Bast RC, Chen MY. A Bayesian approach to dose-response assessment and synergy and its application to in vitro dose-response studies. Biometrics. 66: 1275-83. PMID 20337630 DOI: 10.1111/J.1541-0420.2010.01403.X |
0.335 |
|
| 2009 |
Eng C, Chang GJ, Das P, Rodriguez-Bigas M, Skibber JM, Qiao W, Rosner GL, Ukegbu LT, Wolff RA, Crane CH. Phase II study of capecitabine and oxaliplatin with concurrent radiation therapy (XELOX-XRT) for squamous cell carcinoma of the anal canal. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 4116. PMID 27961220 DOI: 10.1200/Jco.2009.27.15_Suppl.4116 |
0.316 |
|
| 2009 |
Hoskins JM, Rosner GL, Ratain MJ, McLeod HL, Innocenti F. Pharmacodynamic genes do not influence risk of neutropenia in cancer patients treated with moderately high-dose irinotecan. Pharmacogenomics. 10: 1139-46. PMID 19604089 DOI: 10.2217/Pgs.09.35 |
0.341 |
|
| 2009 |
De Iorio M, Johnson WO, Müller P, Rosner GL. Bayesian nonparametric nonproportional hazards survival modeling. Biometrics. 65: 762-71. PMID 19210742 DOI: 10.1111/J.1541-0420.2008.01166.X |
0.353 |
|
| 2008 |
Davies SM, Borowitz MJ, Rosner GL, Ritz K, Devidas M, Winick N, Martin PL, Bowman P, Elliott J, Willman C, Das S, Cook EH, Relling MV. Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood. 111: 2984-90. PMID 18182569 DOI: 10.1182/Blood-2007-09-114082 |
0.303 |
|
| 2008 |
Ding M, Rosner GL, Müller P. Bayesian optimal design for phase II screening trials. Biometrics. 64: 886-94. PMID 18162113 DOI: 10.1111/J.1541-0420.2007.00951.X |
0.535 |
|
| 2008 |
Garcia-Manero G, Yang H, Bueso-Ramos C, Ferrajoli A, Cortes J, Wierda WG, Faderl S, Koller C, Morris G, Rosner G, Loboda A, Fantin VR, Randolph SS, Hardwick JS, Reilly JF, et al. Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes. Blood. 111: 1060-6. PMID 17962510 DOI: 10.1182/Blood-2007-06-098061 |
0.356 |
|
| 2007 |
Müller P, Quintana FA, Rosner GL. Semiparametric bayesian inference for multilevel repeated measurement data. Biometrics. 63: 280-9. PMID 17447954 DOI: 10.1111/J.1541-0420.2006.00668.X |
0.31 |
|
| 2007 |
Kishi S, Cheng C, French D, Pei D, Das S, Cook EH, Hijiya N, Rizzari C, Rosner GL, Frudakis T, Pui CH, Evans WE, Relling MV. Ancestry and pharmacogenetics of antileukemic drug toxicity. Blood. 109: 4151-7. PMID 17264302 DOI: 10.1182/Blood-2006-10-054528 |
0.305 |
|
| 2006 |
Garcia-Manero G, Kantarjian HM, Sanchez-Gonzalez B, Yang H, Rosner G, Verstovsek S, Rytting M, Wierda WG, Ravandi F, Koller C, Xiao L, Faderl S, Estrov Z, Cortes J, O'brien S, et al. Phase 1/2 study of the combination of 5-aza-2'-deoxycytidine with valproic acid in patients with leukemia. Blood. 108: 3271-9. PMID 16882711 DOI: 10.1182/Blood-2006-03-009142 |
0.36 |
|
| 2006 |
Ratain MJ, Eisen T, Stadler WM, Flaherty KT, Kaye SB, Rosner GL, Gore M, Desai AA, Patnaik A, Xiong HQ, Rowinsky E, Abbruzzese JL, Xia C, Simantov R, Schwartz B, et al. Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 2505-12. PMID 16636341 DOI: 10.1200/Jco.2005.03.6723 |
0.303 |
|
| 2006 |
Lichtman SM, Hollis D, Miller AA, Rosner GL, Rhoades CA, Lester EP, Millard F, Byrd J, Cullinan SA, Rosen DM, Parise RA, Ratain MJ, Egorin MJ. Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 1846-51. PMID 16567769 DOI: 10.1200/Jco.2005.03.9289 |
0.301 |
|
| 2006 |
Garcia-Manero G, Bueso-Ramos C, Xiao L, Hoshino K, Rosner G, Pierce S, Yang H. Detection of Residual p73 DNA Methylation Predicts for Shorter Disease Free and Overall Survival in Patients (pts) with Philadelphia (Ph) Chromosome Negative Acute Lymphocytic Leukemia (ALL) in Remission. Blood. 108: 2333-2333. DOI: 10.1182/Blood.V108.11.2333.2333 |
0.301 |
|
| 2005 |
Thrall DE, LaRue SM, Yu D, Samulski T, Sanders L, Case B, Rosner G, Azuma C, Poulson J, Pruitt AF, Stanley W, Hauck ML, Williams L, Hess P, Dewhirst MW. Thermal dose is related to duration of local control in canine sarcomas treated with thermoradiotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 5206-14. PMID 16033838 DOI: 10.1158/1078-0432.Ccr-05-0091 |
0.301 |
|
| 2005 |
Stadler WM, Rosner G, Small E, Hollis D, Rini B, Zaentz SD, Mahoney J, Ratain MJ. Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma--CALGB 69901. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 3726-32. PMID 15923569 DOI: 10.1200/Jco.2005.44.150 |
0.332 |
|
| 2005 |
Peters WP, Rosner GL, Vredenburgh JJ, Shpall EJ, Crump M, Richardson PG, Schuster MW, Marks LB, Cirrincione C, Norton L, Henderson IC, Schilsky RL, Hurd DD. Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 2191-200. PMID 15767638 DOI: 10.1200/Jco.2005.10.202 |
0.31 |
|
| 2005 |
Garcia-Manero G, Kantarjian H, Sanchez-Gonzalez B, Verstovsek S, Ravandi F, Ryttling M, Cortes J, Yang H, Fiorentino J, Rosner G, Issa J. Results of a phase I/II study of the combination of 5-aza-2’-deoxycytidine and valproic acid in patients with acute myeloid leukemia and myelodysplastic syndrome Journal of Clinical Oncology. 23: 6544-6544. DOI: 10.1200/Jco.2005.23.16_Suppl.6544 |
0.309 |
|
| 2005 |
Yang H, Hoshino K, Xiao L, Rosner G, Garcia-Manero G. Aberrant DNA Methylation of a Cell Cycle Regulatory Pathway Composed of p73, p15 and P57kip2 Is Associated with Poor Prognosis in Adult Patients with Philadelphia Chromosome Negative Acute Lymphocytic Leukemia (ALL). Blood. 106: 481-481. DOI: 10.1182/Blood.V106.11.481.481 |
0.306 |
|
| 2005 |
Garcia-Manero G, Kantarjian H, Sanchez-Gonzalez B, Yang H, Rosner G, Verstovsek S, Rytting M, Ravandi F, Faderl S, Estrov Z, Cortes J, O’Brien S, Fiorentino J, Issa J. Final Results of a Phase I/II Study of the Combination of the Hypomethylating Agent 5-aza-2′-Deoxycytidine (DAC) and the Histone Deacetylase Inhibitor Valproic Acid (VPA) in Patients with Leukemia. Blood. 106: 408-408. DOI: 10.1182/Blood.V106.11.408.408 |
0.378 |
|
| 2005 |
Müller P, Rosner GL, De Iorio M, MacEachern S. A nonparametric Bayesian model for inference in related longitudinal studies Journal of the Royal Statistical Society. Series C: Applied Statistics. 54: 611-626. DOI: 10.1111/J.1467-9876.2005.05475.X |
0.361 |
|
| 2004 |
Miller AA, Rosner GL, Egorin MJ, Hollis D, Lichtman SM, Ratain MJ. Prospective evaluation of body surface area as a determinant of paclitaxel pharmacokinetics and pharmacodynamics in women with solid tumors: Cancer and Leukemia Group B Study 9763. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 8325-31. PMID 15623609 DOI: 10.1158/1078-0432.Ccr-04-1078 |
0.308 |
|
| 2004 |
Garcia-Manero G, Kantarjian H, Sanchez-Gonzalez B, Faderl S, Verstovsek S, Ravandi F, Ryttling M, Cortes J, Wierda W, Hoshino K, Yang H, Santos-Malave C, Fiorentino J, Jabbour E, Rosner G, et al. Results of a Phase I/II Study of the Combination of 5-aza-2′-Deoxycytidine (DAC) and Valproic Acid (VPA) in Patients (pts) with Leukemia. Blood. 104: 263-263. DOI: 10.1182/Blood.V104.11.263.263 |
0.34 |
|
| 2003 |
Lopes HF, Müller P, Rosner GL. Bayesian meta-analysis for longitudinal data models using multivariate mixture priors. Biometrics. 59: 66-75. PMID 12762442 DOI: 10.1111/1541-0420.00008 |
0.329 |
|
| 2002 |
Small EJ, Halabi S, Ratain MJ, Rosner G, Stadler W, Palchak D, Marshall E, Rago R, Hars V, Wilding G, Petrylak D, Vogelzang NJ. Randomized Study of Three Different Doses of Suramin Administered With a Fixed Dosing Schedule in Patients With Advanced Prostate Cancer: Results of Intergroup 0159, Cancer and Leukemia Group B 9480 Journal of Clinical Oncology. 20: 3369-3375. PMID 12177096 DOI: 10.1200/Jco.2002.10.022 |
0.363 |
|
| 2002 |
Bass AJ, Gockerman JP, Hammett E, DeCastro CM, Adams DJ, Rosner GL, Payne N, Davis P, Foster T, Moore JO, Rizzieri DA. Phase I evaluation of prolonged-infusion gemcitabine with irinotecan for relapsed or refractory leukemia or lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 2995-3000. PMID 12089230 DOI: 10.1200/Jco.2002.08.166 |
0.314 |
|
| 2002 |
Rizzieri DA, Bass AJ, Rosner GL, Gockerman JP, DeCastro CM, Petros WP, Adams DJ, Laughlin MJ, Davis P, Foster T, Jacobson R, Hurwitz H, Moore JO. Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 674-9. PMID 11821447 DOI: 10.1200/Jco.20.3.674 |
0.301 |
|
| 2001 |
Maguire PD, Samulski TV, Prosnitz LR, Jones EL, Rosner GL, Powers B, Layfield LW, Brizel DM, Scully SP, Harrelson JM, Dewhirst MW. A phase II trial testing the thermal dose parameter CEM43 degrees T90 as a predictor of response in soft tissue sarcomas treated with pre-operative thermoradiotherapy. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 17: 283-90. PMID 11471980 DOI: 10.1080/02656730110039449 |
0.341 |
|
| 2001 |
Gandhi V, Plunkett W, Weller S, Du M, Ayres M, Rodriguez C.O. J, Ramakrishna P, Rosner GL, Hodge JP, O'Brien S, Keating MJ. Evaluation of the combination of nelarabine and fludarabine in leukemias: Clinical response, pharmacokinetics, and pharmacodynamics in leukemia cells Journal of Clinical Oncology. 19: 2142-2152. PMID 11304766 DOI: 10.1200/Jco.2001.19.8.2142 |
0.362 |
|
| 2001 |
Braun RD, Lanzen JL, Turnage JA, Rosner G, Dewhirst MW. Effects of the interaction between carbogen and nicotinamide on R3230 Ac tumor blood flow in Fischer 344 rats. Radiation Research. 155: 724-33. PMID 11302770 DOI: 10.1667/0033-7587(2001)155[0724:Eotibc]2.0.Co;2 |
0.315 |
|
| 2000 |
Thrall DE, Rosner GL, Azuma C, Larue SM, Case BC, Samulski T, Dewhirst MW. Using units of CEM 43 degrees C T90, local hyperthermia thermal dose can be delivered as prescribed. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 16: 415-28. PMID 11001575 DOI: 10.1080/026567300416712 |
0.312 |
|
| 2000 |
Venook AP, Egorin MJ, Rosner GL, Hollis D, Mani S, Hawkins M, Byrd J, Hohl R, Budman D, Meropol NJ, Ratain MJ. Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and leukemia group B 9565 Journal of Clinical Oncology. 18: 2780-2787. PMID 10894879 DOI: 10.1200/Jco.2000.18.14.2780 |
0.363 |
|
| 2000 |
Anscher MS, Lee C, Hurwitz H, Tyler D, Prosnitz LR, Jowell P, Rosner G, Samulski T, Dewhirst MW. A pilot study of preoperative continuous infusion 5-fluorouracil, external microwave hyperthermia, and external beam radiotherapy for treatment of locally advanced, unresectable, or recurrent rectal cancer. International Journal of Radiation Oncology Biology Physics. 47: 719-724. PMID 10837956 DOI: 10.1016/S0360-3016(00)00473-9 |
0.354 |
|
| 1999 |
Marks L, Fitzgerald T, Laurie F, Glicksman A, Rosner G, Vredenburgh J, Shpall E, Crump M, Norton L, Peters W. 94 Preliminary analysis of radiotherapy data from CALGB 9082: variability of treatment fields for local/regional breast cancer and the impact of high dose chemotherapy on the ability to deliver radiation therapy International Journal of Radiation Oncology*Biology*Physics. 45: 195-196. DOI: 10.1016/S0360-3016(99)90112-8 |
0.306 |
|
| 1998 |
Lilenbaum RC, Miller AA, Batist G, Bernard S, Hollis DR, Rosner GL, Egorin MJ, Schilsky RL, Ratain MJ. Phase I and pharmacologic study of continuous infusion topotecan in combination with cisplatin in patients with advanced cancer: A cancer and leukemia group B study Journal of Clinical Oncology. 16: 3302-3309. PMID 9779705 DOI: 10.1200/Jco.1998.16.10.3302 |
0.407 |
|
| 1998 |
Venook AP, Egorin MJ, Rosner GL, Brown TD, Jahan TM, Batist G, Hohl R, Budman D, Ratain MJ, Kearns CM, Schilsky RL. Phase I and pharmacokinetic trial of paclitaxel in patients with hepatic dysfunction: Cancer and leukemia group B 9264 Journal of Clinical Oncology. 16: 1811-1819. PMID 9586895 DOI: 10.1200/Jco.1998.16.5.1811 |
0.378 |
|
| 1997 |
Rosner GL, Müller P. Bayesian population pharmacokinetic and pharmacodynamic analyses using mixture models Journal of Pharmacokinetics and Biopharmaceutics. 25: 209-233. PMID 9408860 DOI: 10.1023/A:1025784113869 |
0.303 |
|
| 1997 |
Müller P, Rosner GL. A Bayesian Population Model with Hierarchical Mixture Priors Applied to Blood Count Data Journal of the American Statistical Association. 92: 1279-1292. DOI: 10.1080/01621459.1997.10473649 |
0.322 |
|
| 1995 |
Gilbert CJ, Ohly KV, Rosner G, Peters WP. Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation. Cancer. 76: 2330-7. PMID 8635039 DOI: 10.1002/1097-0142(19951201)76:11<2330::Aid-Cncr2820761122>3.0.Co;2-F |
0.355 |
|
| 1995 |
Fleming RA, Capizzi RL, Rosner GL, Oliver LK, Smith SJ, Schiffer CA, Silver RT, Peterson BA, Weiss RB, Omura GA. Clinical pharmacology of cytarabine in patients with acute myeloid leukemia: a cancer and leukemia group B study. Cancer Chemotherapy and Pharmacology. 36: 425-30. PMID 7634384 DOI: 10.1007/Bf00686192 |
0.31 |
|
| 1995 |
Brizel DM, Rosner GL, Prosnitz LR, Dewhirst MW. Patterns and variability of tumor oxygenation in human soft tissue sarcomas, cervical carcinomas, and lymph node metastases International Journal of Radiation Oncology, Biology, Physics. 32: 1121-1125. PMID 7607933 DOI: 10.1016/0360-3016(95)00106-9 |
0.314 |
|
| 1995 |
Cartee L, Petros WP, Rosner GL, Gilbert C, Moore S, Affronti ML, Hoke JA, Hussein AM, Ross M, Rubin P, Vredenburgh JJ, Peters WP. Evaluation of GM-CSF mouthwash for prevention of chemotherapy-induced mucositis: a randomized, double-blind, dose-ranging study Cytokine. 7: 471-477. PMID 7578986 DOI: 10.1006/Cyto.1995.0064 |
0.373 |
|
| 1995 |
Lilenbaum RC, Ratain MJ, Miller AA, Hargis JB, Hollis DR, Rosner GL, O'Brien SM, Brewster L, Green MR, Schilsky RL. Phase I study of paclitaxel and topotecan in patients with advanced tumors: A cancer and leukemia group B study Journal of Clinical Oncology. 13: 2230-2237. PMID 7545219 DOI: 10.1200/Jco.1995.13.9.2230 |
0.38 |
|
| 1994 |
Marks LB, Rosner GL, Prosnitz LR, Ross M, Vredenburgh JJ, Peters WP. The impact of conventional plus high dose chemotherapy with autologous bone marrow transplantation on hematologic toxicity during subsequent local- regional radiotherapy for breast cancer Cancer. 74: 2964-2971. PMID 7954260 DOI: 10.1002/1097-0142(19941201)74:11<2964::Aid-Cncr2820741112>3.0.Co;2-X |
0.375 |
|
| 1994 |
Miller AA, Hargis JB, Lilenbaum RC, Fields SZ, Rosner GL, Schilsky RL. Phase I study of topotecan and cisplatin in patients with advanced solid tumors: A cancer and leukemia group B study Journal of Clinical Oncology. 12: 2743-2750. PMID 7527456 DOI: 10.1200/Jco.1994.12.12.2743 |
0.361 |
|
| 1994 |
Rosner GL, Müller P. Pharmacodynamic analysis of hematologic profiles Journal of Pharmacokinetics and Biopharmaceutics. 22: 499-524. PMID 7473079 DOI: 10.1007/Bf02353792 |
0.347 |
|
| 1993 |
Lichtman SM, Ratain MJ, Echo DAV, Rosner G, Egorin MJ, Budman DR, Vogelzang NJ, Norton L, Schilsky RL. Phase I Trial of Granulocyte—Macrophage Colony-Stimulating Factor Plus High-Dose Cyclophosphamide Given Every 2 Weeks: a Cancer and Leukemia Group B Study Journal of the National Cancer Institute. 85: 1319-1326. PMID 8340944 DOI: 10.1093/Jnci/85.16.1319 |
0.388 |
|
| 1992 |
Marks LB, Halperin EC, Prosnitz LR, Ross M, Vredenburgh JJ, Rosner GL, Peters W. Post-mastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer patients with ≥ 10 positive axillary lymph nodes International Journal of Radiation Oncology, Biology, Physics. 23: 1021-1026. PMID 1639635 DOI: 10.1016/0360-3016(92)90908-Z |
0.325 |
|
| 1992 |
Gillette SM, Dewhirst MW, Gillette EL, Thrall DE, Page RL, Powers BE, Withrow SJ, Rosner G, Wong C, Sim DA. Response of canine soft tissue sarcomas to radiation or radiation plus hyperthermia: a randomized phase II study. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 8: 309-20. PMID 1607736 DOI: 10.3109/02656739209021786 |
0.34 |
|
| 1992 |
Page RL, Macy DW, Ogilvie GK, Rosner GL, Dewhirst MW, Thrall DE, Withrow SJ, Mcentee MC, Cline JM, Heidner GL, Novotney CA, Gillette EL. Phase III evaluation of doxorubicin and whole-body hyperthermia in dogs with lymphoma International Journal of Hyperthermia. 8: 187-197. PMID 1573308 DOI: 10.3109/02656739209021774 |
0.302 |
|
| 1992 |
Perfect JR, Klotman ME, Gilbert CC, Crawford DD, Rosner GL, Wright KA, Peters WP. Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients. The Journal of Infectious Diseases. 165: 891-7. PMID 1569339 DOI: 10.1093/Infdis/165.5.891 |
0.312 |
|
| 1992 |
Penta JS, Rosner GL, Trump DL. Choice of starting dose and escalation for phase I studies of antitumor agents Cancer Chemotherapy and Pharmacology. 31: 247-250. PMID 1464163 DOI: 10.1007/Bf00685555 |
0.347 |
|
| 1991 |
Keane TE, Rosner GL, Gingrich JR, Poulton SH, Walther PJ. The therapeutic impact of dipyridamole: chemopotentiation of the cytotoxic combination 5-fluorouracil/cisplatin in an animal model of human bladder cancer. The Journal of Urology. 146: 1418-24. PMID 1942313 DOI: 10.1016/S0022-5347(17)38127-2 |
0.372 |
|
| 1990 |
Keane TE, Rosner G, Donaldson JT, Norwood DL, Poulton SH, Walther PJ. Dipyridamole-cisplatin potentiation: enhanced in vivo cytotoxicity in xenograft models of human testicular and bladder cancers. The Journal of Urology. 144: 1004-9. PMID 2398547 DOI: 10.1016/S0022-5347(17)39647-7 |
0.348 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2008 |
Quintana FA, Müller P, Rosner GL, Relling MV. A Semiparametric Bayesian Model for Repeatedly Repeated Binary Outcomes. Journal of the Royal Statistical Society. Series C, Applied Statistics. 57: 419-431. PMID 19746193 DOI: 10.1111/J.1467-9876.2008.00619.X |
0.299 |
|
| 2018 |
Forde PM, Chaft JE, Smith KN, Anagnostou V, Cottrell TR, Hellmann MD, Zahurak M, Yang SC, Jones DR, Broderick S, Battafarano RJ, Velez MJ, Rekhtman N, Olah Z, Naidoo J, ... ... Rosner GL, et al. Neoadjuvant PD-1 Blockade in Resectable Lung Cancer. The New England Journal of Medicine. PMID 29658848 DOI: 10.1056/Nejmoa1716078 |
0.299 |
|
| 1993 |
Brizel DM, Klitzman B, Cook JM, Edwards J, Rosner G, Dewhirst MW. A comparison of tumor and normal tissue microvascular hematocrits and red cell fluxes in a rat window chamber model International Journal of Radiation Oncology, Biology, Physics. 25: 269-276. PMID 8420874 DOI: 10.1016/0360-3016(93)90348-Y |
0.297 |
|
| 2002 |
Rosner GL, Stadler W, Ratain MJ. Randomized discontinuation design: application to cytostatic antineoplastic agents. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 4478-84. PMID 12431972 DOI: 10.1200/Jco.2002.11.126 |
0.297 |
|
| 2001 |
Müller P, Rosner GL, Inoue LYT, Dewhirst MW. A Bayesian Model for Detecting Acute Change in Nonlinear Profiles Journal of the American Statistical Association. 96: 1215-1222. DOI: 10.1198/016214501753381869 |
0.297 |
|
| 2004 |
De Iorio M, Müller P, Rosner GL, MacEachern SN. An ANOVA Model for Dependent Random Measures Journal of the American Statistical Association. 99: 205-215. DOI: 10.1198/016214504000000205 |
0.296 |
|
| 2009 |
Innocenti F, Kroetz DL, Schuetz E, Dolan ME, Ramírez J, Relling M, Chen P, Das S, Rosner GL, Ratain MJ. Comprehensive pharmacogenetic analysis of irinotecan neutropenia and pharmacokinetics. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 2604-14. PMID 19349540 DOI: 10.1200/Jco.2008.20.6300 |
0.294 |
|
| 2020 |
DeZern AE, Elmariah H, Zahurak M, Rosner GL, Gladstone DE, Ali SA, Huff CA, Swinnen LJ, Imus P, Borrello I, Wagner-Johnston ND, Ambinder RF, Brodsky RA, Cooke K, Luznik L, et al. Shortened-duration immunosuppressive therapy after nonmyeloablative, related HLA-haploidentical or unrelated peripheral blood grafts and post-transplantation cyclophosphamide. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32818556 DOI: 10.1016/J.Bbmt.2020.07.037 |
0.294 |
|
| 2005 |
Eng C, Crane CH, Rosner GL, Rodriguez-Bigas MA, Skibber JM, Bogaard KR, Delclos ME, Lassere YM, Hoff PM, Abbruzzese JL. A phase II study of capecitabine plus oxaliplatin and radiation therpy, XELOX-XRT, in squamous cell carcinoma (SCCA) of the anal canal: A preliminary analysis Journal of Clinical Oncology. 23: 4271-4271. DOI: 10.1200/Jco.2005.23.16_Suppl.4271 |
0.294 |
|
| 2004 |
Kishi S, Cheng C, Pei D, Das S, Cook EH, Hijiya N, Rizzari C, Rosner G, Pui C, Evans WE, Relling MV. Genetic Polymorphisms and the Toxicity of Antileukemic Agents in Children with Acute Lymphoblastic Leukemia. Blood. 104: 1964-1964. DOI: 10.1182/Blood.V104.11.1964.1964 |
0.293 |
|
| 2005 |
Rosner GL. Bayesian monitoring of clinical trials with failure-time endpoints. Biometrics. 61: 239-45. PMID 15737099 DOI: 10.1111/J.0006-341X.2005.031037.X |
0.293 |
|
| 1990 |
Dewhirst MW, Prescott DM, Clegg S, Samulski TV, Page RL, Thrall DE, Leopold K, Rosner G, Acker JC, Oleson JR. The use of hydralazine to manipulate tumour temperatures during hyperthermia. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 6: 971-83. PMID 2286795 DOI: 10.3109/02656739009140980 |
0.292 |
|
| 1993 |
Peters W, Rosner G, Ross M, Vredenburgh J, Meisenberg B, Gilbert C, Kurtzberg J. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy Blood. 81: 1709-1719. DOI: 10.1182/Blood.V81.7.1709.Bloodjournal8171709 |
0.291 |
|
| 1992 |
Dewhirst MW, Ong ET, Madwed D, Klitzman B, Secomb T, Brizel D, Bonaventura J, Rosner G, Kavanagh B, Edwards J, Gross J. Effects of the calcium channel blocker flunarizine on the hemodynamics and oxygenation of tumor microvasculature Radiation Research. 132: 61-68. PMID 1410275 DOI: 10.2307/3578334 |
0.29 |
|
| 2001 |
Stroud JR, Müller P, Rosner GL. Optimal sampling times in population pharmacokinetic studies Journal of the Royal Statistical Society Series C-Applied Statistics. 50: 345-359. DOI: 10.1111/1467-9876.00239 |
0.289 |
|
| 2007 |
Lewis LD, Miller AA, Rosner GL, Dowell JE, Valdivieso M, Relling MV, Egorin MJ, Bies RR, Hollis DR, Levine EG, Otterson GA, Millard F, Ratain MJ. A comparison of the pharmacokinetics and pharmacodynamics of docetaxel between African-American and Caucasian cancer patients: CALGB 9871. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 3302-11. PMID 17545536 DOI: 10.1158/1078-0432.Ccr-06-2345 |
0.286 |
|
| 1992 |
Dewhirst MW, Vinuya RZ, Ong ET, Klitzman B, Rosner G, Secomb TW, Gross JF. Effects of bradykinin on the hemodynamics of tumor and granulating normal tissue microvasculature Radiation Research. 130: 345-354. PMID 1594761 DOI: 10.2307/3578380 |
0.285 |
|
| 1993 |
Dewhirst MW, Madwed D, Meyer RE, Ong ET, Klitzman B, Rosner GL, Dodge R. Reduction in tumor blood flow in skin flap tumor after hydralazine is not due to a vascular steal phenomenon Radiation Oncology Investigations. 1: 270-278. DOI: 10.1002/Roi.2970010504 |
0.285 |
|
| 2011 |
Müller P, Quintana F, Rosner GL. A Product Partition Model With Regression on Covariates. Journal of Computational and Graphical Statistics : a Joint Publication of American Statistical Association, Institute of Mathematical Statistics, Interface Foundation of North America. 20: 260-278. PMID 21566678 DOI: 10.1198/Jcgs.2011.09066 |
0.284 |
|
| 2013 |
Xu H, Haddad H, Anders R, Arslankoz S, Wang H, Zhang Z, Rapp S, Wood LS, Netto GJ, Drake CG, Rosner GL, Rini BI. B7H1 expression and association with clinical response to sunitinib therapy in patients with metastatic renal cell carcinoma (mRCC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 416. PMID 28137145 DOI: 10.1200/Jco.2013.31.6_Suppl.416 |
0.284 |
|
| 1997 |
Shan SQ, Rosner GL, Braun RD, Hahn J, Pearce C, Dewhirst MW. Effects of diethylamine/nitric oxide on blood perfusion and oxygenation in the R3230Ac mammary carcinoma British Journal of Cancer. 76: 429-437. PMID 9275018 DOI: 10.1038/Bjc.1997.406 |
0.284 |
|
| 2004 |
Kishi S, Yang W, Boureau B, Morand S, Das S, Chen P, Cook EH, Rosner GL, Schuetz E, Pui CH, Relling MV. Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia. Blood. 103: 67-72. PMID 12969965 DOI: 10.1182/Blood-2003-06-2105 |
0.283 |
|
| 1997 |
Hahn JS, Braun RD, Dewhirst MW, Shan S, Snyder SA, Taube JM, Ong ET, Rosner GL, Dodge RK, Bonaventura J, Bonaventura C, Deangelo J, Meyer RE. Stroma-free human hemoglobin A decreases R3230Ac rat mammary adenocarcinoma blood flow and oxygen partial pressure Radiation Research. 147: 185-194. PMID 9008211 DOI: 10.2307/3579420 |
0.283 |
|
| 2008 |
Thompson PA, Gupta M, Rosner GL, Yu A, Barrett J, Bomgaars L, Bernstein ML, Blaney SM, Mondick J. Pharmacokinetics of irinotecan and its metabolites in pediatric cancer patients: a report from the children's oncology group. Cancer Chemotherapy and Pharmacology. 62: 1027-37. PMID 18278496 DOI: 10.1007/S00280-008-0692-Z |
0.278 |
|
| 1995 |
Rosner GL, Berry DA. A Bayesian group sequential design for a multiple arm randomized clinical trial Statistics in Medicine. 14: 381-394. PMID 7746978 DOI: 10.1002/Sim.4780140405 |
0.278 |
|
| 2007 |
Rossell D, Müller P, Rosner GL. Screening designs for drug development. Biostatistics (Oxford, England). 8: 595-608. PMID 17030589 DOI: 10.1093/Biostatistics/Kxl031 |
0.276 |
|
| 2008 |
Rosner GL, Panetta JC, Innocenti F, Ratain MJ. Pharmacogenetic pathway analysis of irinotecan Clinical Pharmacology and Therapeutics. 84: 393-402. PMID 18418374 DOI: 10.1038/Clpt.2008.63 |
0.276 |
|
| 2006 |
Klein CE, Kastrissios H, Miller AA, Hollis D, Yu D, Rosner GL, Grinblatt DL, Larson RA, Ratain MJ. Pharmacokinetics, pharmacodynamics and adherence to oral topotecan in myelodysplastic syndromes: a Cancer and Leukemia Group B study. Cancer Chemotherapy and Pharmacology. 57: 199-206. PMID 16158312 DOI: 10.1007/S00280-005-0023-6 |
0.275 |
|
| 2012 |
Wu D, Kafadar K, Rosner GL, Broemeling LD. The lead time distribution when lifetime is subject to competing risks in cancer screening. The International Journal of Biostatistics. 8. PMID 22611589 DOI: 10.1515/1557-4679.1363 |
0.275 |
|
| 1994 |
Cline JM, Thrall DE, Rosner GL, Raleigh JA. Distribution of the hypoxia marker CCI-103F in canine tumors International Journal of Radiation Oncology, Biology, Physics. 28: 921-933. PMID 8138446 DOI: 10.1016/0360-3016(94)90113-9 |
0.273 |
|
| 2009 |
Yang H, Kadia T, Xiao L, Bueso-Ramos CE, Hoshino K, Thomas DA, O'Brien S, Jabbour E, Pierce S, Rosner GL, Kantarjian HM, Garcia-Manero G. Residual DNA methylation at remission is prognostic in adult Philadelphia chromosome-negative acute lymphocytic leukemia. Blood. 113: 1892-8. PMID 19109226 DOI: 10.1182/Blood-2008-02-141002 |
0.272 |
|
| 2014 |
Wu D, Kafadar K, Rosner GL. Inference of long term effects and overdiagnosis in periodic cancer screening Statistica Sinica. 24: 815-831. DOI: 10.5705/Ss.2012.067 |
0.271 |
|
| 1994 |
Brizel DM, Rosner GL, Harrelson J, Prosnitz LR, Dewhirst MW. Pretreatment oxygenation profiles of human soft tissue sarcomas International Journal of Radiation Oncology, Biology, Physics. 30: 635-642. PMID 7928495 DOI: 10.1016/0360-3016(92)90950-M |
0.27 |
|
| 1998 |
Acker JC, Marks LB, Spencer DP, Yang W, Avery MA, Dodge RK, Rosner GL, Dewhirst MW. Serial in vivo observations of cerebral vasculature after treatment with a large single fraction of radiation. Radiation Research. 149: 350-9. PMID 9525499 DOI: 10.2307/3579697 |
0.27 |
|
| 1997 |
Thrall DE, Rosner GL, Azuma C, McEntee MC, Raleigh JA. Hypoxia marker labeling in tumor biopsies: quantification of labeling variation and criteria for biopsy sectioning. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 44: 171-6. PMID 9288846 DOI: 10.1016/S0167-8140(97)01931-2 |
0.269 |
|
| 1993 |
Wu NZ, Klitzman B, Rosner G, Needham D, Dewhirst MW. Measurement of Material Extravasation in Microvascular Networks Using Fluorescence Video-Microscopy Microvascular Research. 46: 231-253. PMID 8246821 DOI: 10.1006/Mvre.1993.1049 |
0.269 |
|
| 2000 |
Meyer RE, Braun RD, Rosner GL, Dewhirst MW. Local 42°C hyperthermia improves vascular conductance of the R3230Ac rat mammary adenocarcinoma during sodium nitroprusside infusion Radiation Research. 154: 196-201. PMID 10931692 DOI: 10.1667/0033-7587(2000)154[0196:Lchivc]2.0.Co;2 |
0.268 |
|
| 2005 |
Wu D, Rosner GL, Broemeling L. MLE and Bayesian inference of age-dependent sensitivity and transition probability in periodic screening. Biometrics. 61: 1056-63. PMID 16401279 DOI: 10.1111/J.1541-0420.2005.00361.X |
0.267 |
|
| 2004 |
Muller P, Quintana F, Rosner G. A method for combining inference across related nonparametric Bayesian models Journal of the Royal Statistical Society: Series B (Statistical Methodology). 66: 735-749. DOI: 10.1111/J.1467-9868.2004.05564.X |
0.267 |
|
| 1996 |
Miller AA, Lilenbaum RC, Lynch TJ, Rosner GL, Ratain MJ, Green MR, Schilsky RL. Treatment-related fatal sepsis from topotecan/cisplatin and topotecan/paclitaxel [1] Journal of Clinical Oncology. 14: 1964. PMID 8656268 DOI: 10.1200/Jco.1996.14.6.1964 |
0.262 |
|
| 2008 |
Quintana FA, Müler P, Rosner GL, Munsell M. Semi-parametric Bayesian Inference for Multi-Season Baseball Data. Bayesian Analysis (Online). 3: 317-338. PMID 21909346 DOI: 10.1214/08-Ba312 |
0.261 |
|
| 2013 |
Forde PM, Bagheri A, Ahn J, Forastiere AA, Frick KD, Rosner GL, Dy SM, Smith TJ. Measuring the impact of chemotherapy cost discussions between patients and providers at the time of prescribing. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 257. PMID 28136414 DOI: 10.1200/Jco.2013.31.31_Suppl.257 |
0.261 |
|
| 2001 |
Snyder SA, Lanzen JL, Braun RD, Rosner G, Secomb TW, Biaglow J, Brizel DM, Dewhirst MW. Simultaneous administration of glucose and hyperoxic gas achieves greater improvement in tumor oxygenation than hyperoxic gas alone International Journal of Radiation Oncology Biology Physics. 51: 494-506. PMID 11567826 DOI: 10.1016/S0360-3016(01)01654-6 |
0.26 |
|
| 2007 |
Wu D, Rosner GL, Broemeling LD. Bayesian inference for the lead time in periodic cancer screening. Biometrics. 63: 873-80. PMID 17825017 DOI: 10.1111/J.1541-0420.2006.00732.X |
0.26 |
|
| 2009 |
Wu D, Erwin D, Rosner GL. A projection of benefits due to fecal occult blood test for colorectal cancer. Cancer Epidemiology. 33: 212-5. PMID 19733140 DOI: 10.1016/J.Canep.2009.08.001 |
0.259 |
|
| 1997 |
Cline JM, Rosner GL, Raleigh JA, Thrall DE. Quantification of CCI-103F labeling heterogeneity in canine solid tumors International Journal of Radiation Oncology Biology Physics. 37: 655-662. PMID 9112464 DOI: 10.1016/S0360-3016(96)00559-7 |
0.258 |
|
| 1989 |
Rosner GL, Tsiatis AA. The impact that group sequential tests would have made on ECOG clinical trials Statistics in Medicine. 8: 505-516. PMID 2657957 DOI: 10.1002/Sim.4780080413 |
0.258 |
|
| 2007 |
Ghosh P, Rosner GL. A semi-parametric Bayesian approach to average bioequivalence. Statistics in Medicine. 26: 1224-36. PMID 16832840 DOI: 10.1002/Sim.2620 |
0.255 |
|
| 1996 |
Rosner GL, Clegg ST, Prescott DM, Dewhirst MW. Estimation of cell survival in tumours heated to nonuniform temperature distributions. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 12: 223-39. PMID 8926391 DOI: 10.3109/02656739609022511 |
0.251 |
|
| 1997 |
Samuels BL, Hollis DR, Rosner GL, Trump DL, Shapiro CL, Vogelzang NJ, Schilsky RL. Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 3: 1977-84. PMID 9815587 |
0.25 |
|
| 2009 |
Wu D, Erwin D, Rosner GL. Estimating key parameters in FOBT screening for colorectal cancer. Cancer Causes & Control : Ccc. 20: 41-6. PMID 18704710 DOI: 10.1007/S10552-008-9215-9 |
0.249 |
|
| 1984 |
Tsiatis AA, Rosner GL, Mehta CR. Exact confidence intervals following a group sequential test Biometrics. 40: 797-803. PMID 6518248 DOI: 10.2307/2530924 |
0.248 |
|
| 2015 |
Webster JA, Tibes R, Blackford A, Morris L, Patnaik MM, Wang L, Rebechi M, Greer J, Litzow MR, Karnitz L, Rosner GL, Doyle A, Kaufmann SH, Karp JE, Smith BD. Randomized Phase II Trial of Timed Sequential Cytosine Arabinoside with and without the CHK1 Inhibitor MK-8876 in Adults with Relapsed and Refractory Acute Myelogenous Leukemia Blood. 126: 2563-2563. DOI: 10.1182/Blood.V126.23.2563.2563 |
0.247 |
|
| 1994 |
Clegg ST, Samulski TV, Murphy KA, Rosner GL, Dewhirst MW. Inverse techniques in hyperthermia: a sensitivity study. Ieee Transactions On Bio-Medical Engineering. 41: 373-82. PMID 8063303 DOI: 10.1109/10.284965 |
0.247 |
|
| 2007 |
Han X, Garcia-Manero G, McDonnell TJ, Lozano G, Medeiros LJ, Xiao L, Rosner G, Nguyen M, Fernandez M, Valentin-Vega YA, Barboza J, Jones DM, Rassidakis GZ, Kantarjian HM, Bueso-Ramos CE. HDM4 (HDMX) is widely expressed in adult pre-B acute lymphoblastic leukemia and is a potential therapeutic target. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 20: 54-62. PMID 17143258 DOI: 10.1038/Modpathol.3800727 |
0.242 |
|
| 1999 |
Prosnitz LR, Maguire P, Anderson JM, Scully SP, Harrelson JM, Jones EL, Dewhirst M, Samulski TV, Powers BE, Rosner GL, Dodge RK, Layfield L, Clough R, Brizel DM. The treatment of high-grade soft tissue sarcomas with preoperative thermoradiotherapy. International Journal of Radiation Oncology, Biology, Physics. 45: 941-9. PMID 10571201 DOI: 10.1016/S0360-3016(99)00272-2 |
0.242 |
|
| 1996 |
Thrall DE, Prescott DM, Samulski TV, Rosner GL, Denman DL, Legorreta RL, Dodge RK, Page RL, Cline JM, Lee J, Case BC, Evans SM, Oleson JR, Dewhirst MW. Radiation plus local hyperthermia versus radiation plus the combination of local and whole-body hyperthermia in canine sarcomas. International Journal of Radiation Oncology, Biology, Physics. 34: 1087-96. PMID 8600092 DOI: 10.1016/0360-3016(95)02260-0 |
0.241 |
|
| 2004 |
Wu MH, Chen P, Wu X, Liu W, Strom S, Das S, Cook EH, Rosner GL, Dolan ME. Determination and analysis of single nucleotide polymorphisms and haplotype structure of the human carboxylesterase 2 gene. Pharmacogenetics. 14: 595-605. PMID 15475733 DOI: 10.1097/00008571-200409000-00004 |
0.241 |
|
| 1991 |
Shpall EJ, Jones RB, Bast RC, Rosner GL, Vandermark R, Ross M, Affronti ML, Johnston C, Eggteston S, Tepperburg M, Coniglio D, Peters WP. 4-hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: A phase I trial Journal of Clinical Oncology. 9: 85-93. PMID 1985173 DOI: 10.1200/Jco.1991.9.1.85 |
0.241 |
|
| 2000 |
Meyer RE, Braun RD, Rosner GL, Dewhirst MW. Nitroprusside improves tumor perfusion during local 42°C hyperthermia. Veterinary Anaesthesia and Analgesia. 27: 105. PMID 28404033 DOI: 10.1016/S1467-2987(16)31354-X |
0.24 |
|
| 1994 |
Brizel DM, Rosner G, Dewhirst MW. An evaluation of the patterns and variability of tumor oxygenation in human soft tissue sarcomas and cervical cervical carcinomas International Journal of Radiation Oncology*Biology*Physics. 30: 207. DOI: 10.1016/0360-3016(94)90718-8 |
0.239 |
|
| 2003 |
Venook AP, Klein CE, Fleming G, Hollis D, Leichman CG, Hohl R, Byrd J, Budman D, Villalona M, Marshall J, Rosner GL, Ramirez J, Kastrissios H, Ratain MJ. A phase I and pharmacokinetic study of irinotecan in patients with hepatic or renal dysfunction or with prior pelvic radiation: CALGB 9863 Annals of Oncology. 14: 1783-1790. PMID 14630685 DOI: 10.1093/Annonc/Mdg493 |
0.239 |
|
| 2023 |
Cremaschi A, Yang W, De Iorio M, Evans W, Yang J, Rosner G. Bayesian modelling of response to therapy and drug-sensitivity in acute lymphoblastic leukemia. Research Square. PMID 36865272 DOI: 10.21203/rs.3.rs-2542277/v1 |
0.235 |
|
| 1996 |
Petros WP, Rosner GL, Rabinowitz J, Gilbert CJ, Coniglio D, Vredenburgh JJ, Ross M, Peters WP. The pharmacologic effects of recombinant, human colony-stimulating factors and their modulation by theophylline. Pharmacotherapy. 16: 742-8. PMID 8888069 DOI: 10.1002/J.1875-9114.1996.Tb02991.X |
0.235 |
|
| 2017 |
Paller CJ, Heath EI, Taplin M, Stein MN, Bubley GJ, Pili R, Mayer TM, Zhou XC, Hudson T, Abbas M, Anders N, Dowling D, KIng S, Drake CG, Antonarakis ES, ... ... Rosner GL, et al. A phase II study of muscadine grape skin extract in men with biochemically recurrent prostate cancer. Journal of Clinical Oncology. 35: 248-248. DOI: 10.1200/Jco.2017.35.6_Suppl.248 |
0.234 |
|
| 2009 |
Gu X, Frankowski RF, Rosner GL, Relling M, Peng B, Amos CI. A modified forward multiple regression in high-density genome-wide association studies for complex traits. Genetic Epidemiology. 33: 518-25. PMID 19365845 DOI: 10.1002/Gepi.20404 |
0.233 |
|
| 2011 |
Wu D, Erwin D, Rosner GL. Sojourn time and lead time projection in lung cancer screening. Lung Cancer (Amsterdam, Netherlands). 72: 322-6. PMID 21075475 DOI: 10.1016/J.Lungcan.2010.10.010 |
0.233 |
|
| 2009 |
Innocenti F, Mirkov S, Nagasubramanian R, Ramírez J, Liu W, Bleibel WK, Shukla SJ, Hennessy K, Rosner GL, Cook E, Eileen Dolan M, Ratain MJ. The Werner's syndrome 4330T>C (Cys1367Arg) gene variant does not affect the in vitro cytotoxicity of topoisomerase inhibitors and platinum compounds. Cancer Chemotherapy and Pharmacology. 63: 881-7. PMID 18677484 DOI: 10.1007/S00280-008-0793-8 |
0.233 |
|
| 2005 |
Bueso-Ramos C, Xu Y, McDonnell TJ, Brisbay S, Pierce S, Kantarjian H, Rosner G, Garcia-Manero G. Protein expression of a triad of frequently methylated genes, p73, p57Kip2, and p15, has prognostic value in adult acute lymphocytic leukemia independently of its methylation status. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 3932-9. PMID 15851765 DOI: 10.1200/Jco.2005.02.998 |
0.232 |
|
| 2011 |
Cruz-Marcelo A, Ensor KB, Rosner GL. Estimating the Term Structure With a Semiparametric Bayesian Hierarchical Model: An Application to Corporate Bonds. Journal of the American Statistical Association. 106: 387-395. PMID 21765566 DOI: 10.1198/Jasa.2011.Ap09764 |
0.23 |
|
| 2007 |
Thompson PA, Murry DJ, Rosner GL, Lunagomez S, Blaney SM, Berg SL, Camitta BM, Dreyer ZE, Bomgaars LR. Methotrexate pharmacokinetics in infants with acute lymphoblastic leukemia. Cancer Chemotherapy and Pharmacology. 59: 847-53. PMID 17136402 DOI: 10.1007/S00280-006-0388-1 |
0.228 |
|
| 2004 |
Relling MV, Yang W, Das S, Cook EH, Rosner GL, Neel M, Howard S, Ribeiro R, Sandlund JT, Pui CH, Kaste SC. Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 3930-6. PMID 15459215 DOI: 10.1200/Jco.2004.11.020 |
0.228 |
|
| 2005 |
Shen L, Kondo Y, Rosner GL, Xiao L, Hernandez NS, Vilaythong J, Houlihan PS, Krouse RS, Prasad AR, Einspahr JG, Buckmeier J, Alberts DS, Hamilton SR, Issa JP. MGMT promoter methylation and field defect in sporadic colorectal cancer. Journal of the National Cancer Institute. 97: 1330-8. PMID 16174854 DOI: 10.1093/Jnci/Dji275 |
0.227 |
|
| 1999 |
Dunn TJ, Braun RD, Rhemus WE, Rosner GL, Secomb TW, Tozer GM, Chaplin DJ, Dewhirst MW. The effects of hyperoxic and hypercarbic gases on tumour blood flow. British Journal of Cancer. 80: 117-26. PMID 10389987 DOI: 10.1038/Sj.Bjc.6690330 |
0.226 |
|
| 2004 |
Schuetz EG, Relling MV, Kishi S, Yang W, Das S, Chen P, Cook EH, Rosner GL, Pui CH, Blanco JG, Edick MJ, Hancock ML, Winick NJ, Dervieux T, Amylon MD, et al. PharmGKB update: II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5. Pharmacological Reviews. 56: 159. PMID 15169924 DOI: 10.1124/Pr.56.2.1 |
0.223 |
|
| 2009 |
Thompson PA, Rosner GL, Matthay KK, Moore TB, Bomgaars LR, Ellis KJ, Renbarger J, Berg SL. Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network study. Cancer Chemotherapy and Pharmacology. 64: 243-51. PMID 19020877 DOI: 10.1007/S00280-008-0854-Z |
0.221 |
|
| 2020 |
Reuss JE, Sepesi B, Rolfo CD, Zahurak M, Anagnostou V, Smith KN, Cottrell T, Stein JE, Illei PB, Taube JM, Rosner GL, Murray JC, Nakajima EC, Voong KR, Hales RK, et al. Trial in progress: Neoadjuvant immune checkpoint blockade in resectable malignant pleural mesothelioma. Journal of Clinical Oncology. 38: TPS9078-TPS9078. DOI: 10.1200/jco.2020.38.15_suppl.tps9078 |
0.219 |
|
| 2008 |
Müller P, Rosner GL. Discussion of "Simple, Defensible Sample Sizes Based on Cost Efficiency," by P. Bacchetti, C. E. McCulloch, and M. R. Segal Biometrics. DOI: 10.1111/J.1541-0420.2008.01006.X |
0.214 |
|
| 1997 |
Miller AA, Rosner GL, Ratain MJ, Hollis DR, Green MR, Schilsky RL. Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: A cancer and leukemia group B study (CALGB 9062) Clinical Cancer Research. 3: 719-725. PMID 9815741 |
0.213 |
|
| 2020 |
Connolly RM, Laille E, Vaishampayan U, Chung V, Kelly K, Dowlati A, Alese OB, Harvey RD, Haluska P, Siu LL, Kummar S, Piekarz RL, Ivy SP, Anders NM, Downs M, ... ... Rosner GL, et al. Phase I and Pharmacokinetic Study of Romidepsin in Patients with Cancer and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32816943 DOI: 10.1158/1078-0432.Ccr-20-1412 |
0.213 |
|
| 1999 |
Kaz A, Snyder S, Braun R, Rosner G, Pulowski J, Bonaventura J, Stamler J, Tozer G, Wilson H, Dewhirst M. 2005 S-nitrosohemoglobin modifies blood flow in rat mammary adenocarcinoma International Journal of Radiation Oncology*Biology*Physics. 45: 281-282. DOI: 10.1016/S0360-3016(99)90275-4 |
0.213 |
|
| 2002 |
Fleming GF, Meropol NJ, Rosner GL, Hollis DR, Carson WE, Caligiuri M, Mortimer J, Tkaczuk K, Parihar R, Schilsky RL, Ratain MJ. A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 8: 3718-27. PMID 12473581 |
0.205 |
|
| 2015 |
Lombardi LR, Kanakry C, Zahurak M, Durakovic N, Bolaños-Meade J, Kasamon YL, Gladstone DE, Matsui W, Borrello I, Huff CA, Swinnen LJ, Brodsky RA, Ambinder RF, Fuchs EJ, Rosner GL, et al. Therapeutic drug monitoring for either oral or intravenous busulfan when combined with pre- and post-transplantation cyclophosphamide. Leukemia & Lymphoma. 1-30. PMID 26292764 DOI: 10.3109/10428194.2015.1071488 |
0.205 |
|
| 2016 |
Redmond KJ, Hales RK, Zhou XC, Kummerlowe M, Sair H, Duhon M, Kleinberg LR, Rosner G, Vannorsdall T. A Prospective Study of Hippocampal-Sparing Prophylactic Cranial Irradiation (PCI) in Limited-Stage Small Cell Lung Cancer (SCLC). International Journal of Radiation Oncology, Biology, Physics. 96: S57. PMID 27675962 DOI: 10.1016/J.Ijrobp.2016.06.148 |
0.201 |
|
| 2018 |
Shroff RT, Yarchoan M, O'Connor A, Gallagher D, Zahurak ML, Rosner G, Ohaji C, Sartorius-Mergenthaler S, Parkinson R, Subbiah V, Zinner R, Azad NS. The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma. British Journal of Cancer. PMID 29315294 DOI: 10.1038/Bjc.2017.418 |
0.199 |
|
| 2014 |
Müller P, Quintana FA, Rosner GL, Maitland ML. Bayesian inference for longitudinal data with non-parametric treatment effects. Biostatistics (Oxford, England). 15: 341-52. PMID 24285773 DOI: 10.1093/Biostatistics/Kxt049 |
0.195 |
|
| 2015 |
Crona DJ, Ramirez J, Qiao W, de Graan AJ, Ratain MJ, van Schaik RH, Mathijssen RH, Rosner GL, Innocenti F. Clinical validity of new genetic biomarkers of irinotecan neutropenia: an independent replication study. The Pharmacogenomics Journal. PMID 25869015 DOI: 10.1038/tpj.2015.23 |
0.194 |
|
| 2018 |
Hobbs BP, Barata PC, Kanjanapan Y, Paller CJ, Perlmutter J, Pond GR, Prowell TM, Rubin EH, Seymour LK, Wages NA, Yap TA, Feltquate D, Garrett-Mayer E, Grossman W, Hong DS, ... ... Rosner GL, et al. Seamless Designs: Current Practice and Considerations for Early-Phase Drug Development in Oncology. Journal of the National Cancer Institute. PMID 30561713 DOI: 10.1093/Jnci/Djy196 |
0.193 |
|
| 2011 |
Kasamon YL, Luznik L, Leffell MS, Tsai H, Symons HJ, Bolaños-Meade J, Rosner G, Morris LE, Crilley PA, Jones RJ, Fuchs EJ. Significance of Missing Inhibitory KIR Ligands in Nonmyeloablative, HLA-Haploidentical (Haplo) BMT with Posttransplantation High-Dose Cyclophosphamide (PT/Cy) Blood. 118: 840-840. DOI: 10.1182/blood.v118.21.840.840 |
0.192 |
|
| 2018 |
Lee V, Wang JS, Zahurak ML, Gootjes EC, Verheul HMW, Parkinson RM, Kerner Z, Sharma A, Rosner GL, De Jesus-Acosta A, Laheru DA, Le DT, Oganesian A, Lilly-Foreman E, Brown T, et al. A phase I trial of a guadecitabine (SGI-110) and irinotecan in metastatic colorectal cancer patients previously exposed to irinotecan. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30097434 DOI: 10.1158/1078-0432.Ccr-18-0421 |
0.191 |
|
| 2012 |
Trippa L, Rosner GL, Müller P. Bayesian enrichment strategies for randomized discontinuation trials. Biometrics. 68: 203-11. PMID 21714780 DOI: 10.1111/J.1541-0420.2011.01623.X |
0.189 |
|
| 2017 |
Day D, Monjazeb AM, Sharon E, Ivy SP, Rubin EH, Rosner GL, Butler MO. From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials Wisely. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 23: 4980-4991. PMID 28864726 DOI: 10.1158/1078-0432.Ccr-16-3064 |
0.189 |
|
| 2017 |
Llosa NJ, Cooke KR, Chen A, Gamper C, Klein O, Zambidis E, Luber B, Rosner G, Siegel N, Holuba MJ, Robey N, Hayashi M, Jones RJ, Fuchs E, Holdhoff M, et al. Reduced Intensity Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Solid Tumors in Pediatric and Young Adult Patients. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 28807769 DOI: 10.1016/j.bbmt.2017.08.012 |
0.187 |
|
| 2015 |
Seymour L, Groshen S, Rosner GL, Sullivan DM, Spriggs DR, Reeves S, Gravell A, Ivy SP, Ratain MJ. Impact of the 2010 Consensus Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 5057-63. PMID 26567365 DOI: 10.1158/1078-0432.Ccr-15-0035 |
0.186 |
|
| 2018 |
Kasamon YL, Fuchs EJ, Zahurak M, Rosner GL, Symons HJ, Gladstone DE, Huff CA, Swinnen LJ, Brodsky RA, Matsui WH, Borrello I, Shanbhag S, Cooke KR, Ambinder RF, Luznik L, et al. Shortened-Duration Tacrolimus after Nonmyeloablative, HLA-Haploidentical BMT. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29353109 DOI: 10.1016/j.bbmt.2018.01.011 |
0.183 |
|
| 1997 |
Müller P, Rosner GL. A Bayesian population model with hierarchical mixture priors applied to blood count data Journal of the American Statistical Association. 92: 1279-1292. |
0.183 |
|
| 2014 |
Paller CJ, Bradbury PA, Ivy SP, Seymour L, LoRusso PM, Baker L, Rubinstein L, Huang E, Collyar D, Groshen S, Reeves S, Ellis LM, Sargent DJ, Rosner GL, LeBlanc ML, et al. Design of phase I combination trials: recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 4210-7. PMID 25125258 DOI: 10.1158/1078-0432.Ccr-14-0521 |
0.181 |
|
| 2015 |
Zeidner JF, Foster MC, Blackford AL, Litzow MR, Morris LE, Strickland SA, Lancet JE, Bose P, Levy MY, Tibes R, Gojo I, Gocke CD, Rosner GL, Little RF, Wright JJ, et al. Randomized multicenter phase 2 study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia. Haematologica. PMID 26022709 DOI: 10.3324/haematol.2015.125849 |
0.18 |
|
| 2021 |
Bever KM, Thomas DL, Zhang J, Diaz Rivera EA, Rosner GL, Zhu Q, Nauroth JM, Christmas B, Thompson ED, Anders RA, Judkins C, Liu M, Jaffee EM, Ahuja N, Zheng L, et al. A feasibility study of combined epigenetic and vaccine therapy in advanced colorectal cancer with pharmacodynamic endpoint. Clinical Epigenetics. 13: 25. PMID 33531075 DOI: 10.1186/s13148-021-01014-8 |
0.18 |
|
| 1996 |
Rosner GL, Hargis JB, Hollis DR, Budman DR, Weiss RB, Henderson IC, Schilsky RL. Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: Results from Cancer and Leukemia Group B study 8541 Journal of Clinical Oncology. 14: 3000-3008. PMID 8918498 |
0.178 |
|
| 2003 |
Rizzieri DA, Ibom VK, Moore JO, DeCastro CM, Rosner GL, Adams DJ, Foster T, Payne N, Thompson M, Vredenburgh JJ, Gasparetto C, Long GD, Chao NJ, Gockerman JP. Phase I evaluation of prolonged-infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 663-8. PMID 12576433 |
0.178 |
|
| 2014 |
Paller CJ, Olatoye D, Xie S, Zhou X, Denmeade SR, Eisenberger MA, Antonarakis ES, Carducci MA, Rosner GL. The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer Prostate Cancer and Prostatic Diseases. 17: 28-33. PMID 24100642 DOI: 10.1038/pcan.2013.40 |
0.176 |
|
| 2015 |
McCurdy SR, Kanakry JA, Showel MM, Tsai HL, Bolaños-Meade J, Rosner GL, Kanakry CG, Perica K, Symons HJ, Brodsky RA, Gladstone DE, Huff CA, Pratz KW, Prince GT, Dezern AE, et al. Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide. Blood. 125: 3024-31. PMID 25814532 DOI: 10.1182/blood-2015-01-623991 |
0.175 |
|
| 2023 |
Lee SHR, Yang W, Gocho Y, John A, Rowland L, Smart B, Williams H, Maxwell D, Hunt J, Yang W, Crews KR, Roberts KG, Jeha S, Cheng C, Karol SE, ... ... Rosner GL, et al. Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response. Nature Medicine. PMID 36604538 DOI: 10.1038/s41591-022-02112-7 |
0.175 |
|
| 2014 |
McCurdy SR, Kanakry CG, Kasamon YL, Bolanos Meade J, Tsai H, Showel MM, Kanakry JA, Symons HJ, Rosner GL, Fuchs EJ, Jones RJ, Luznik L. Graft-Versus-Host Disease (GVHD) and Survival Outcomes after HLA-Haploidentical (Haplo) Bone Marrow Transplant (BMT) Compare Favorably with Matched Related Donor (MRD), and Matched Unrelated Donor (MUD) BMT Utilizing High-Dose Posttransplantation Cyclophosphamide (PTCy) Blood. 124: 730-730. DOI: 10.1182/BLOOD.V124.21.730.730 |
0.175 |
|
| 2012 |
Karrison TG, Ratain MJ, Stadler WM, Rosner GL. Estimation of Progression-Free Survival for All Treated Patients in the Randomized Discontinuation Trial Design. The American Statistician. 66: 155-162. PMID 24039273 DOI: 10.1080/00031305.2012.720900 |
0.171 |
|
| 2014 |
Kanakry CG, Tsai HL, Bolaños-Meade J, Smith BD, Gojo I, Kanakry JA, Kasamon YL, Gladstone DE, Matsui W, Borrello I, Huff CA, Swinnen LJ, Powell JD, Pratz KW, DeZern AE, ... ... Rosner GL, et al. Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS. Blood. 124: 3817-27. PMID 25316679 DOI: 10.1182/Blood-2014-07-587477 |
0.171 |
|
| 2019 |
Paller CJ, Huang EP, Luechtefeld T, Massett HA, Williams CC, Zhao J, Gravell AE, Tamashiro T, Reeves SA, Rosner GL, Carducci MA, Rubinstein L, Ivy SP. Factors Affecting Combination Trial Success (FACTS): Investigator Survey Results on Early-Phase Combination Trials. Frontiers in Medicine. 6: 122. PMID 31214592 DOI: 10.3389/fmed.2019.00122 |
0.169 |
|
| 2015 |
Kasamon YL, Fuchs EJ, Bolaños-Meade J, Leffell MS, Zahurak M, Rosner GL, Powell JD, Ambinder RF, Jones RJ, Luznik L. Nonmyeloablative (NMA), HLA-Mismatched Unrelated Donor (mMUD) BMT with High-Dose Posttransplantation Cyclophosphamide (PTCy) Has Outcomes Similar to Matched BMT Blood. 126: 2002-2002. DOI: 10.1182/BLOOD.V126.23.2002.2002 |
0.168 |
|
| 2017 |
Kasamon YL, Ambinder RF, Fuchs EJ, Zahurak M, Rosner GL, Bolaños-Meade J, Levis MJ, Gladstone DE, Huff CA, Swinnen LJ, Matsui WH, Borrello I, Brodsky RA, Jones RJ, Luznik L. Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide. Blood Advances. 1: 288-292. PMID 29242852 DOI: 10.1182/bloodadvances.2016002766 |
0.166 |
|
| 2022 |
Vega DM, Nishimura KK, Zariffa N, Thompson JC, Hoering A, Cilento V, Rosenthal A, Anagnostou V, Baden J, Beaver JA, Chaudhuri AA, Chudova D, Fine AD, Fiore J, Hodge R, ... ... Rosner GL, et al. Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors. Jco Precision Oncology. 6: e2100372. PMID 35952319 DOI: 10.1200/PO.21.00372 |
0.163 |
|
| 2012 |
Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, Hryniuk WM, Morrison VA, Pini TM, Runowicz CD, Rosner GL, Shayne M, Sparreboom A, Sucheston LE, Lyman GH. Appropriate chemotherapy dosing for obese adult patients with cancer: American Society of Clinical Oncology clinical practice guideline. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 1553-61. PMID 22473167 DOI: 10.1200/JCO.2011.39.9436 |
0.162 |
|
| 2011 |
Innocenti F, Rosner GL, Qiao W, de Graan AM, Ratain MJ, van Schaik RH, Ramirez J, Mathijssen R. An independent, external validation study of proposed genetic biomarkers of irinotecan toxicity and pharmacokinetics. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e14022. PMID 28022580 DOI: 10.1200/jco.2011.29.15_suppl.e14022 |
0.161 |
|
| 2019 |
Pratz KW, Rudek MA, Smith BD, Karp J, Gojo I, Dezern A, Jones RJ, Greer J, Gocke C, Baer MR, Duong VH, Rosner G, Zahurak M, Wright JJ, Emadi A, et al. A prospective study of peri-transplant sorafenib for FLT3-ITD AML patients undergoing allogeneic transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 31550496 DOI: 10.1016/J.Bbmt.2019.09.023 |
0.161 |
|
| 2018 |
Marrone KA, Zhou X, Forde PM, Purtell M, Brahmer JR, Hann CL, Kelly RJ, Coleman B, Gabrielson E, Rosner GL, Ettinger DS. A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy-Naïve Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer. The Oncologist. PMID 29487223 DOI: 10.1634/theoncologist.2017-0465 |
0.16 |
|
| 2017 |
McCurdy SR, Kanakry CG, Tsai HL, Kasamon YL, Showel MM, Bolaños-Meade J, Huff CA, Borrello I, Matsui WH, Brodsky RA, Ambinder RF, Bettinotti MP, Fuchs EJ, Rosner GL, Jones RJ, et al. Grade II Acute GVHD and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Posttransplant Cyclophosphamide. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29055682 DOI: 10.1016/j.bbmt.2017.10.023 |
0.159 |
|
| 2015 |
Noonan KA, Huff CA, Davis J, Lemas MV, Fiorino S, Bitzan J, Ferguson A, Emerling A, Luznik L, Matsui W, Powell J, Fuchs E, Rosner GL, Epstein C, Rudraraju L, et al. Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma. Science Translational Medicine. 7: 288ra78. PMID 25995224 DOI: 10.1126/Scitranslmed.Aaa7014 |
0.159 |
|
| 2011 |
Ramsey LB, Bruun GH, Yang W, Trevino LR, Vattathil S, Scheet P, Cheng C, Rosner G, Giacomini K, Fan Y, Sparreboom A, Mikkelsen T, Corydon TJ, Pui C, Evans WE, et al. SLCO1B1 Variation and Methotrexate Disposition in Children with Acute Lymphoblastic Leukemia: The Importance of Rare Variants in Pharmacogenetics Blood. 118: 571-571. DOI: 10.1182/Blood.V118.21.571.571 |
0.158 |
|
| 2023 |
Baretti M, Murphy AG, Zahurak M, Gianino N, Parkinson R, Walker R, Lopez-Vidal TY, Zheng L, Rosner G, Ahuja N, Kurt S, Azad NS. A study of using epigenetic modulators to enhance response to pembrolizumab (MK-3475) in microsatellite stable advanced colorectal cancer. Clinical Epigenetics. 15: 74. PMID 37120591 DOI: 10.1186/s13148-023-01485-x |
0.157 |
|
| 2001 |
Stroud JR, Müller P, Rosner GL. Optimal sampling times in population pharmacokinetic studies Journal of the Royal Statistical Society. Series C: Applied Statistics. 50: 345-359. |
0.156 |
|
| 2023 |
Hahn NM, O'Donnell MA, Efstathiou JA, Zahurak M, Rosner GL, Smith J, Kates MR, Bivalacqua TJ, Tran PT, Song DY, Baras AS, Matoso A, Choi W, Smith KN, Pardoll DM, et al. A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study. European Urology. PMID 36717286 DOI: 10.1016/j.eururo.2023.01.017 |
0.155 |
|
| 2013 |
Cruz-Marcelo A, Rosner GL, Müller P, Stewart CF. Effect on Prediction when Modeling Covariates in Bayesian Nonparametric Models. Journal of Statistical Theory and Practice. 7: 204-218. PMID 23687472 DOI: 10.1080/15598608.2013.772811 |
0.155 |
|
| 2021 |
Wang Z, Wang F, Wang C, Zhang J, Wang H, Shi L, Tang Z, Rosner GL. A Bayesian decision-theoretic design for simultaneous biomarker-based subgroup selection and efficacy evaluation. Statistics in Biopharmaceutical Research. 14: 568-579. PMID 37197312 DOI: 10.1080/19466315.2021.1873843 |
0.154 |
|
| 2020 |
Hong H, Wang C, Rosner GL. Meta-analysis of rare adverse events in randomized clinical trials: Bayesian and frequentist methods. Clinical Trials (London, England). 1740774520969136. PMID 33258698 DOI: 10.1177/1740774520969136 |
0.154 |
|
| 2017 |
Webster JA, Tibes R, Morris L, Blackford AL, Litzow M, Patnaik M, Rosner GL, Gojo I, Kinders R, Wang L, Doyle LA, Huntoon CJ, Karnitz LM, Kaufmann SH, Karp JE, et al. Randomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemia. Leukemia Research. 61: 108-116. PMID 28957699 DOI: 10.1016/J.Leukres.2017.09.005 |
0.152 |
|
| 2015 |
Ivanova A, Anderson KM, Rosner GL, Rubin E. Comment. Statistics in Biopharmaceutical Research. 7: 357-358. PMID 30416674 DOI: 10.1080/19466315.2015.1094407 |
0.15 |
|
| 2011 |
Chen MY, Liao WS, Lu Z, Bornmann WG, Hennessey V, Washington MN, Rosner GL, Yu Y, Ahmed AA, Bast RC. Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy. Cancer. 117: 4424-38. PMID 21491416 DOI: 10.1002/Cncr.26073 |
0.15 |
|
| 2015 |
Zeidner JF, Zahurak M, Rosner GL, Gocke CD, Jones RJ, Smith BD. The evolution of treatment strategies for patients with chronic myeloid leukemia relapsing after allogeneic bone marrow transplant: can tyrosine kinase inhibitors replace donor lymphocyte infusions? Leukemia & Lymphoma. 56: 128-34. PMID 24712979 DOI: 10.3109/10428194.2014.910868 |
0.15 |
|
| 2017 |
Barcella W, De Iorio M, Favaro S, Rosner GL. Dependent generalized Dirichlet process priors for the analysis of acute lymphoblastic leukemia. Biostatistics (Oxford, England). PMID 28968716 DOI: 10.1093/biostatistics/kxx042 |
0.146 |
|
| 2017 |
Marrone K, Forde P, Brahmer J, Rosner G, Zhou X, Coleman B, Ettinger D. P2.03a-010 A Randomized Phase II Study of Platinum-Based Chemotherapy +/- Metformin in Chemotherapy-Naïve Advanced Non-Squamous NSCLC Journal of Thoracic Oncology. 12: S893. DOI: 10.1016/j.jtho.2016.11.1219 |
0.146 |
|
| 2010 |
Yang Y, Müller P, Rosner GL. Semiparametric Bayesian inference for repeated fractional measurement data. Chilean Journal of Statistics. 1: 59-74. PMID 21822354 |
0.145 |
|
| 2004 |
Lewis LD, Rosner GL, Miller AA, Egorin MJ, Relling MV, Kastrissios H, Bies R, Ratain MJ. The pharmacokinetics and pharmacodynamics of docetaxel (DCTX) in Caucasian and African American patients with solid tumors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 2043. PMID 28015624 DOI: 10.1200/Jco.2004.22.14_Suppl.2043 |
0.143 |
|
| 2014 |
Zeidner JF, Foster MC, Blackford A, Litzow MR, Morris L, Strickland SA, Lancet JE, Bose P, Levy MY, Tibes R, Gojo I, Gocke CD, Rosner GL, Greer J, Cain JM, et al. Randomized multicenter phase II trial of timed-sequential therapy with flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus “7+3” for adults with newly diagnosed acute myeloid leukemia (AML). Journal of Clinical Oncology. 32: 7002-7002. DOI: 10.1200/JCO.2014.32.15_SUPPL.7002 |
0.142 |
|
| 2019 |
Wang C, Rosner GL. A Bayesian nonparametric causal inference model for synthesizing randomized clinical trial and real-world evidence. Statistics in Medicine. PMID 30883861 DOI: 10.1002/sim.8134 |
0.142 |
|
| 2018 |
Rosner GL. Bayesian approaches to evaluating doses of drugs. Clinical Advances in Hematology & Oncology : H&O. 16: 258-261. PMID 29742080 |
0.139 |
|
| 2018 |
Zeidner JF, Foster MC, Blackford AL, Litzow MR, Morris LE, Strickland SA, Lancet JE, Bose P, Levy MY, Tibes R, Gojo I, Gocke CD, Rosner GL, Little RF, Wright JJ, et al. Final results of a randomized multicenter phase II study of alvocidib, cytarabine, and mitoxantrone versus cytarabine and daunorubicin (7 + 3) in newly diagnosed high-risk acute myeloid leukemia (AML). Leukemia Research. 72: 92-95. PMID 30118897 DOI: 10.1016/j.leukres.2018.08.005 |
0.136 |
|
| 2018 |
Wang C, Rosner GL, Roden RBS. A Bayesian design for phase I cancer therapeutic vaccine trials. Statistics in Medicine. PMID 30368868 DOI: 10.1002/sim.8021 |
0.135 |
|
| 2016 |
Pratz KW, Rudek MA, Gojo I, Litzow MR, McDevitt MA, Ji JJ, Karnitz L, Herman JG, Kinders R, Smith BD, Gore SD, Carraway H, Showel MM, Gladstone DE, Levis MJ, ... ... Rosner GL, et al. A Phase I study of topotecan, carboplatin and the PARP inhibitor veliparib in acute leukemias, aggressive myeloproliferative neoplasms and chronic myelomonocytic leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27551000 DOI: 10.1158/1078-0432.Ccr-16-1274 |
0.134 |
|
| 2016 |
Kasamon YL, Fuchs EJ, Zahurak M, Rosner GL, Symons HJ, Bolaños-Meade J, Jones RJ. Shortened-Duration Tacrolimus after Nonmyeloablative HLA-Haploidentical (NMA haplo) BMT with High-Dose Posttransplantation Cyclophosphamide (PTCy) Facilitates Strategies for Relapse Reduction Blood. 128: 831-831. DOI: 10.1182/BLOOD.V128.22.831.831 |
0.133 |
|
| 2014 |
Kelly RJ, Forde PM, Bagheri A, Ahn J, Forastiere AA, Elnahal S, Rosner GL, Smith TJ. Patients and physicians can discuss the actual costs of cancer treatment with high interest and little conflict. Journal of Clinical Oncology. 32: 6563-6563. DOI: 10.1200/jco.2014.32.15_suppl.6563 |
0.133 |
|
| 2021 |
Griggs JJ, Bohlke K, Balaban EP, Dignam JJ, Hall ET, Harvey RD, Hecht DP, Klute KA, Morrison VA, Pini TM, Rosner GL, Runowicz CD, Shayne M, Sparreboom A, Turner S, et al. Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2100471. PMID 33939491 DOI: 10.1200/JCO.21.00471 |
0.133 |
|
| 2012 |
Ramsey LB, Bruun GH, Yang W, Treviño LR, Vattathil S, Scheet P, Cheng C, Rosner GL, Giacomini KM, Fan Y, Sparreboom A, Mikkelsen TS, Corydon TJ, Pui CH, Evans WE, et al. Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition. Genome Research. 22: 1-8. PMID 22147369 DOI: 10.1101/Gr.129668.111 |
0.132 |
|
| 2018 |
Litvak A, Batukbhai B, Russell SD, Tsai HL, Rosner GL, Jeter SC, Armstrong D, Emens LA, Fetting J, Wolff AC, Silhy R, Stearns V, Connolly RM. Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer. Cancer. PMID 29381193 DOI: 10.1002/cncr.31260 |
0.131 |
|
| 2015 |
Kanakry JA, Gocke CD, Bolaños-Meade J, Gladstone DE, Swinnen LJ, Blackford AL, Fuchs EJ, Huff CA, Borrello I, Matsui WH, Brodsky RA, Rosner GL, Shanbhag S, Luznik L, Jones RJ, et al. Phase II Study of Nonmyeloablative Allogeneic Bone Marrow Transplantation for B Cell Lymphoma with Post-Transplantation Rituximab and Donor Selection Based First on Non-HLA Factors. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 26183076 DOI: 10.1016/j.bbmt.2015.07.012 |
0.13 |
|
| 2018 |
Elmariah H, Kasamon YL, Zahurak M, Macfarlane KW, Tucker N, Rosner GL, Bolaños-Meade J, Fuchs EJ, Wagner-Johnston N, Swinnen LJ, Huff CA, Matsui WH, Gladstone DE, McCurdy SR, Borrello I, et al. Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide Using Non-First-Degree Related Donors. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29452245 DOI: 10.1016/j.bbmt.2018.02.005 |
0.13 |
|
| 2020 |
O'Donnell PH, Trubetskoy V, Nurhussein-Patterson A, Hall JP, Nath A, Huo D, Fleming GF, Ingle JN, Abramson VG, Morrow PK, Storniolo AM, Forero A, Van Poznak C, Liu MC, Chang JC, ... ... Rosner GL, et al. Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015. Breast Cancer Research and Treatment. PMID 32378051 DOI: 10.1007/S10549-020-05603-8 |
0.128 |
|
| 2012 |
Paller CJ, Xie S, Olatoye D, Denmeade SR, Eisenberger MA, Antonarakis ES, Carducci MA, Rosner GL. The effect of PSA frequency and duration on PSA doubling time (PSADT) calculations in men with biochemically recurrent prostate cancer (BRPC) after definitive local therapy. Journal of Clinical Oncology. 30: 4559-4559. DOI: 10.1200/Jco.2012.30.15_Suppl.4559 |
0.124 |
|
| 1988 |
Rosner GL, Tsiatis AA. Exact confidence intervals following a group sequential trial: A comparison of methods Biometrika. 75: 723-729. DOI: 10.1093/biomet/75.4.723 |
0.123 |
|
| 2022 |
Wang C, Lin M, Rosner GL, Soon G. A Bayesian model with application for adaptive platform trials having temporal changes. Biometrics. PMID 35476298 DOI: 10.1111/biom.13680 |
0.123 |
|
| 2011 |
Jara A, Hanson TE, Quintana FA, Müller P, Rosner GL. DPpackage: Bayesian Non- and Semi-parametric Modelling in R. Journal of Statistical Software. 40: 1-30. PMID 21796263 |
0.123 |
|
| 2021 |
Wang C, Rosner GL, Bao T, Lu N, Chen WC, Li H, Tiwari R, Xu Y, Yue LQ. Leveraging real-world evidence for determining performance goals for medical device studies. Statistics in Medicine. PMID 34561895 DOI: 10.1002/sim.9199 |
0.121 |
|
| 1985 |
Tsiatis AA, Rosner GL, Tritchler DL. Group sequential tests with censored survival data adjusting for covariates Biometrika. 72: 365-373. DOI: 10.1093/biomet/72.2.365 |
0.12 |
|
| 2018 |
Santa-Maria CA, Bardia A, Blackford AL, Snyder C, Connolly RM, Fetting JH, Hayes DF, Jeter SC, Miller RS, Nguyen A, Quinlan K, Rosner GL, Slater S, Storniolo AM, Wolff AC, et al. A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial. Breast Cancer Research and Treatment. PMID 29752687 DOI: 10.1007/S10549-018-4811-1 |
0.117 |
|
| 2015 |
Kasamon YL, Bolaños-Meade J, Prince GT, Tsai HL, McCurdy SR, Kanakry JA, Rosner GL, Brodsky RA, Perica K, Smith BD, Gladstone DE, Swinnen LJ, Showel MM, Matsui WH, Huff CA, et al. Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26261255 DOI: 10.1200/JCO.2014.60.4777 |
0.115 |
|
| 2020 |
Rosner GL. Bayesian Methods in Regulatory Science. Statistics in Biopharmaceutical Research. 12: 130-136. PMID 32489520 DOI: 10.1080/19466315.2019.1668843 |
0.113 |
|
| 2016 |
Parsons HA, Beaver JA, Cimino-Mathews A, Ali SM, Axilbund J, Chu D, Connolly R, Cochran R, Croessmann S, Clark T, Gocke CD, Jeter SC, Kennedy M, Lauring J, Lee J, ... ... Rosner GL, et al. Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple Negative Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27489289 DOI: 10.1158/1078-0432.Ccr-16-1543 |
0.112 |
|
| 2020 |
Reuss JE, Anagnostou V, Cottrell TR, Smith KN, Verde F, Zahurak M, Lanis M, Murray JC, Chan HY, McCarthy C, Wang D, White JR, Yang S, Battafarano R, Broderick S, ... ... Rosner G, et al. Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer. Journal For Immunotherapy of Cancer. 8. PMID 32929052 DOI: 10.1136/jitc-2020-001282 |
0.111 |
|
| 2015 |
Kelly RJ, Forde PM, Elnahal SM, Forastiere AA, Rosner GL, Smith TJ. Patients and Physicians Can Discuss Costs of Cancer Treatment in the Clinic. Journal of Oncology Practice / American Society of Clinical Oncology. 11: 308-12. PMID 26015459 DOI: 10.1200/JOP.2015.003780 |
0.109 |
|
| 2010 |
Erb TO, von Ungern-Sternberg BS, Keller K, Rosner GL, Craig D, Frei FJ. Fentanyl does not reduce the incidence of laryngospasm in children anesthetized with sevoflurane. Anesthesiology. 113: 41-7. PMID 20508496 DOI: 10.1097/ALN.0b013e3181dcd875 |
0.108 |
|
| 2015 |
Paller CJ, Rudek MA, Zhou XC, Wagner WD, Hudson TS, Anders N, Hammers HJ, Dowling D, King S, Antonarakis ES, Drake CG, Eisenberger MA, Denmeade SR, Rosner GL, Carducci MA. A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determination. The Prostate. PMID 26012728 DOI: 10.1002/Pros.23024 |
0.104 |
|
| 2020 |
Wang C, Wang Z, Rosner GL, Huh WK, Roden RBS, Bae S. A batch-effect adjusted Simon's two-stage design for cancer vaccine clinical studies. Biometrics. PMID 32822525 DOI: 10.1111/Biom.13358 |
0.102 |
|
| 1995 |
Pham SM, Keenan RJ, Rao AS, Fontes PA, Kormos RL, Abu-Elmagd K, Zeevi A, Kawai A, Hattler BG, Hardesty RL, Demetris AJ, Trucco MM, Rosner GL, Fung JJ, Starzl TE, et al. Perioperative donor bone marrow infusion augments chimerism in heart and lung transplant recipients The Annals of Thoracic Surgery. 60: 1015-1020. PMID 7574940 DOI: 10.1016/0003-4975(95)00579-A |
0.102 |
|
| 2016 |
Gerber JM, Zeidner JF, Morse S, Blackford AL, Perkins B, Yanagisawa B, Zhang H, Morsberger L, Karp J, Ning Y, Gocke CD, Rosner GL, Smith BD, Jones RJ. Association of Acute Myeloid Leukemia's Most Immature Phenotype with Risk Groups and Outcomes. Haematologica. PMID 26819054 DOI: 10.3324/Haematol.2015.135194 |
0.098 |
|
| 2016 |
McCurdy SR, Kasamon YL, Kanakry CG, Bolaños-Meade J, Tsai HL, Showel MM, Kanakry JA, Symons HJ, Gojo I, Smith BD, Bettinotti MP, Matsui WH, Dezern AE, Huff CA, Borrello I, ... ... Rosner GL, et al. Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with posttransplantation cyclophosphamide. Haematologica. PMID 27846611 DOI: 10.3324/haematol.2016.144139 |
0.096 |
|
| 2017 |
Redmond KJ, Hales RK, Anderson-Keightly H, Zhou XC, Kummerlowe M, Sair HI, Duhon M, Kleinberg L, Rosner GL, Vannorsdall T. Prospective Study of Hippocampal-Sparing Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. 98: 603-611. PMID 28581401 DOI: 10.1016/J.Ijrobp.2017.03.009 |
0.095 |
|
| 2015 |
Shroff RT, O'Connor A, Gallagher D, Zahurak M, Rosner GL, Ohaji C, Sartorius-Mergenthaler S, Zinner R, Azad NS. Pazopanib (P) and trametinib (T) in advanced cholangiocarcinoma (CC): A phase Ib study. Journal of Clinical Oncology. 33: 4072-4072. DOI: 10.1200/JCO.2015.33.15_SUPPL.4072 |
0.092 |
|
| 2017 |
Shroff RT, Yarchoan M, O'Connor A, Gallagher D, Zahurak ML, Rosner G, Ohaji C, Sartorius-Mergenthaler S, Subbiah V, Zinner R, Azad NS. The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma. British Journal of Cancer. PMID 28441383 DOI: 10.1038/bjc.2017.119 |
0.092 |
|
| 2018 |
McCurdy SR, Kanakry CG, Tsai HL, Gojo I, Smith BD, Gladstone DE, Bolaños-Meade J, Borrello I, Matsui WH, Swinnen LJ, Huff CA, Brodsky RA, Ambinder RF, Fuchs EJ, Rosner GL, et al. Development of Grade II Acute Graft-Versus-Host Disease is Associated with Improved Survival after Myeloablative HLA-Matched Bone Marrow Transplantation using Single-Agent Post-Transplant Cyclophosphamide. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30599208 DOI: 10.1016/j.bbmt.2018.12.767 |
0.092 |
|
| 2018 |
Paller CJ, Huang E, Luechtefeld T, Massett HA, Williams C, Zhao J, Gravell A, Reeves SA, Rosner GL, Carducci MA, Rubinstein L, Ivy SP. FACTS: Factors affecting combination trial success. Journal of Clinical Oncology. 36: 2544-2544. DOI: 10.1200/jco.2018.36.15_suppl.2544 |
0.089 |
|
| 2016 |
Wang H, Rosner GL, Goodman SN. Quantifying over-estimation in early stopped clinical trials and the "freezing effect" on subsequent research. Clinical Trials (London, England). PMID 27271682 DOI: 10.1177/1740774516649595 |
0.089 |
|
| 2005 |
Innocenti F, Undevia SD, Rosner GL, Xiao L, Liu W, Chen P, Das S, Ramirez J, Kroetz DL, Ratain MJ. Irinotecan (CPT-11) pharmacokinetics (PK) and neutropenia: interaction among UGT1A1 and transporter genes. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 2006. PMID 27946805 DOI: 10.1200/Jco.2005.23.16_Suppl.2006 |
0.089 |
|
| 2014 |
Ivanova A, Rosner GL, Marchenko O, Parke T, Perevozskaya I, Wang Y. Advances in Statistical Approaches Oncology Drug Development. Therapeutic Innovation & Regulatory Science. 48: 81-89. PMID 25949927 DOI: 10.1177/2168479013501309 |
0.088 |
|
| 2017 |
Paller CJ, Zhou XC, Heath EI, Taplin ME, Mayer T, Stein MN, Bubley GJ, Pili R, Hudson T, Kakarla R, Abbas MM, Anders NM, Dowling D, King S, Bruns AB, ... ... Rosner GL, et al. Muscadine Grape Skin Extract in Men with Biochemically Recurrent Prostate Cancer: A Randomized, Multicenter, Placebo-Controlled Clinical Trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29113986 DOI: 10.1158/1078-0432.Ccr-17-1100 |
0.088 |
|
| 1996 |
Dewhirst MW, Ong ET, Rosner GL, Rehmus SW, Shan S, Braun RD, Brizel DM, Secomb TW. Arteriolar oxygenation in tumour and subcutaneous arterioles: effects of inspired air oxygen content The British Journal of Cancer. Supplement. 27: S241-246. PMID 8763889 |
0.084 |
|
| 2013 |
Qin L, Smith BD, Tsai HL, Yaghi NK, Neela PH, Moake M, Fu J, Kasamon YL, Prince GT, Goswami M, Rosner GL, Levitsky HI, Hourigan CS. Induction of high-titer IgG antibodies against multiple leukemia-associated antigens in CML patients with clinical responses to K562/GVAX immunotherapy Blood Cancer Journal. 3. DOI: 10.1038/bcj.2013.44 |
0.083 |
|
| 1996 |
Rosner GL, Clegg ST, Prescott DM, Dewhirst MW. Estimation of cell survival in tumours heated to nonuniform temperature distributions. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 12: 303-4. PMID 8926397 |
0.082 |
|
| 2020 |
O'Sullivan CC, Irshad S, Wang Z, Tang Z, Umbricht C, Rosner GL, Christianson MS, Stearns V, Smith KL. Clinico-pathologic features, treatment and outcomes of breast cancer during pregnancy or the post-partum period. Breast Cancer Research and Treatment. PMID 32162192 DOI: 10.1007/s10549-020-05585-7 |
0.081 |
|
| 2020 |
Ivanova A, Israel E, LaVange LM, Peters MC, Denlinger LC, Moore WC, Bacharier LB, Marquis MA, Gotman NM, Kosorok MR, Tomlinson C, Mauger DT, Georas SN, Wright RJ, Noel P, ... Rosner GL, et al. The precision interventions for severe and/or exacerbation-prone asthma (PrecISE) adaptive platform trial: statistical considerations. Journal of Biopharmaceutical Statistics. 1-12. PMID 32941098 DOI: 10.1080/10543406.2020.1821705 |
0.08 |
|
| 2016 |
Forde PM, Smith K, Chaft JE, Hellmann MD, Merghoub T, Wolchok JD, Yang SC, Battafarano RJ, Gabrielson E, Georgiades C, Verde F, Rosner GL, Anagnostou V, Velculescu VE, Topalian SL, et al. Neoadjuvant anti-PD1, nivolumab, in early stage resectable non-small-cell lung cancer. Journal of Clinical Oncology. 34: e20005-e20005. DOI: 10.1200/Jco.2016.34.15_Suppl.E20005 |
0.078 |
|
| 2017 |
Siu LL, Ivy SP, Dixon EL, Gravell AE, Reeves SA, Rosner GL. Challenges and Opportunities in Adapting Clinical Trial Design for Immunotherapies. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 23: 4950-4958. PMID 28864723 DOI: 10.1158/1078-0432.CCR-16-3079 |
0.074 |
|
| 2013 |
Holdhoff M, Rosner GL, Alcorn S, Grossman SA. 'Elderly' patients with newly diagnosed glioblastoma deserve optimal care. Journal of Neuro-Oncology. 113: 343-4. PMID 23526408 DOI: 10.1007/s11060-013-1113-7 |
0.071 |
|
| 1987 |
Weil SC, Rosner GL, Reid MS, Chisholm RL, Farber NM, Spitznagel JK, Swanson MS. cDNA cloning of human myeloperoxidase: Decrease in myeloperoxidase mRNA upon induction of HL-60 cells Proceedings of the National Academy of Sciences of the United States of America. 84: 2057-2061. PMID 3031662 DOI: 10.1073/Pnas.84.7.2057 |
0.071 |
|
| 2020 |
Rosner GL, Müller P. Discussion on "Predictively consistent prior effective sample sizes," by Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, and Anthony O'Hagan. Biometrics. PMID 32251527 DOI: 10.1111/Biom.13254 |
0.069 |
|
| 2015 |
Gerber JM, Zeidner JF, Morse S, Blackford A, Perkins B, Yanagisawa B, Zhang H, Morsberger L, Karp JE, Ning Y, Gocke CD, Rosner GL, Smith BD, Jones RJ. Correlation of acute myeloid leukemia (AML) stem cell phenotype with cytogenetic/molecular features and prognosis. Journal of Clinical Oncology. 33: 7000-7000. DOI: 10.1200/Jco.2015.33.15_Suppl.7000 |
0.069 |
|
| 2021 |
Tannock IF, Ratain MJ, Goldstein DA, Lichter AS, Rosner GL, Saltz LB. Near-Equivalence: Generating Evidence to Support Alternative Cost-Effective Treatments. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2002768. PMID 33555940 DOI: 10.1200/JCO.20.02768 |
0.068 |
|
| 1988 |
Weil SC, Rosner GL, Reid MS, Chisholm RL, Lemons RS, Swanson MS, Carrino JJ, Diaz MO, Le Beau MM. Translocation and rearrangement of myeloperoxidase gene in acute promyelocytic leukemia. Science (New York, N.Y.). 240: 790-2. PMID 2896388 DOI: 10.1126/Science.2896388 |
0.066 |
|
| 2001 |
Müller P, Rosner GL, Inoue LYT, Dewhirst MW. A Bayesian Model for Detecting Acute Change in Nonlinear Profiles Journal of the American Statistical Association. 96: 1215-1222. |
0.065 |
|
| 2020 |
Spiker J, Kreimeyer K, Dang O, Boxwell D, Chan V, Cheng C, Gish P, Lardieri A, Wu E, De S, Naidoo J, Lehmann H, Rosner GL, Ball R, Botsis T. Information Visualization Platform for Postmarket Surveillance Decision Support. Drug Safety. PMID 32445187 DOI: 10.1007/s40264-020-00945-0 |
0.062 |
|
| 2020 |
Cristiano S, McKean D, Carey J, Bracci P, Brennan P, Chou M, Du M, Gallinger S, Goggins MG, Hassan MM, Hung RJ, Kurtz RC, Li D, Lu L, Neale R, ... ... Rosner GL, et al. Bayesian copy number detection and association in large-scale studies. Bmc Cancer. 20: 856. PMID 32894098 DOI: 10.1186/S12885-020-07304-3 |
0.057 |
|
| 1994 |
DiPietro L, Ostfeld AM, Rosner GL. Adiposity and stroke among older adults of low socioeconomic status: The Chicago Stroke Study American Journal of Public Health. 84: 14-19. PMID 8279605 DOI: 10.2105/Ajph.84.1.14 |
0.057 |
|
| 2005 |
Lindner J, Rosner GL. Moving beyond manual media migration Archiving 2005 - Final Program and Proceedings. 2005: 193-196. |
0.057 |
|
| 2021 |
Kreimeyer K, Dang O, Spiker J, Muñoz MA, Rosner G, Ball R, Botsis T. Feature engineering and machine learning for causality assessment in pharmacovigilance: Lessons learned from application to the FDA Adverse Event Reporting System. Computers in Biology and Medicine. 135: 104517. PMID 34130003 DOI: 10.1016/j.compbiomed.2021.104517 |
0.056 |
|
| 2016 |
Forde P, Smith K, Chaft J, Hellmann M, Merghoub T, Wolchok J, Yang S, Battafarano R, Gabrielson E, Georgiades C, Verde F, Rosner G, Naidoo J, Cottrell T, Taube J, et al. NSCLC, early stage Neoadjuvant anti-PD1, nivolumab, in early stage resectable non-small-cell lung cancer Annals of Oncology. 27: vi576. DOI: 10.1093/Annonc/Mdw435.38 |
0.055 |
|
| 2011 |
Jara A, Hanson TE, Quintana FA, Müller P, Rosner GL. DPpackage: Bayesian semi- and nonparametric modeling in R Journal of Statistical Software. 40: 1-30. |
0.055 |
|
| 1989 |
Miller CW, Rovera G, Venturelli D, Huebner KF, Van Tuinen P, Ledbetter DH, Kitchingman G, Mirro J, Koeffler HP, Donti E, Montanucci M, Longo L, Mencarelli A, Pandolfi P, Tabilio A, ... ... Rosner GL, et al. The myeloperoxidase gene in acute promyelocytic leukemia Science. 244: 823-826. PMID 2543068 |
0.054 |
|
| 1989 |
Rosmarin AG, Weil SC, Rosner GL, Griffin JD, Arnaout MA, Tenen DG. Differential expression of CD11b/CD18 (Mo1) and myeloperoxidase genes during myeloid differentiation Blood. 73: 131-136. PMID 2562920 DOI: 10.1182/Blood.V73.1.131.Bloodjournal731131 |
0.053 |
|
| 2016 |
McCurdy S, Kanakry C, Kasamon Y, Tsai H, Showel M, Bolanos-Meade J, Kanakry J, Symons H, Gojo I, Smith BD, Bettinotti M, Fuchs E, Rosner G, Jones R. Risk Factors for Graft-Versus-Host Disease after HLA-Haploidentical Transplantation with Posttransplantation Cyclophosphamide Clinical Lymphoma Myeloma and Leukemia. 16: S125-S126. DOI: 10.1016/j.clml.2016.07.183 |
0.051 |
|
| 2010 |
Nallari AS, Karrison T, Rosner GL, Levine MR, Sit L, Wu K, Stadler WM, Ratain MJ, Cohen EE, Maitland ML. Fasting glucose and triglycerides as biomarkers of mTOR inhibition, evidence of a categorical response. Journal of Clinical Oncology. 28: 3091-3091. DOI: 10.1200/jco.2010.28.15_suppl.3091 |
0.041 |
|
| 1988 |
Miki T, Weil SC, Rosner GL, Reid MS, Kidd KK. An MPO cDNA clone identifies an RFLP with PstI. Nucleic Acids Research. 16: 1649. PMID 2894639 DOI: 10.1093/Nar/16.4.1649 |
0.028 |
|
| 1991 |
Rosner GL. Chemistry: Use of DNA probes in paternity testing Clinical Laboratory Science. 4: 336-337. PMID 10150130 |
0.026 |
|
| 2008 |
Müller P, Rosner GL. Discussions Biometrics. 64: 587-589. DOI: 10.1111/j.1541-0420.2008.01004_3.x |
0.014 |
|
| 2011 |
Trippa L, Rosner GL, Muller P. Rejoinder Biometrics. DOI: 10.1111/j.1541-0420.2011.01628.x |
0.01 |
|
| Hide low-probability matches. |